Acorah Software Products - Accounts Production 19.2.450 false true false true No description of principal activity 1 April 2025 31 March 2026 31 March 2026 16314801 Dr René Van Der Merwe iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16314801 2025-03-31 16314801 2026-03-31 16314801 2025-04-01 2026-03-31 16314801 frs-core:CurrentFinancialInstruments 2026-03-31 16314801 frs-bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 16314801 frs-bus:FilletedAccounts 2025-04-01 2026-03-31 16314801 frs-bus:Micro-entities 2025-04-01 2026-03-31 16314801 frs-bus:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 16314801 frs-bus:Director1 2025-04-01 2026-03-31
Registered number: 16314801
Dynamic Pharma Consulting Ltd
Unaudited Financial Statements
For The Year Ended 31 March 2026
Jaggar Accountants Ltd
Dynamic Pharma Consulting Ltd
Balance Sheet
As At 31 March 2026
Balance Sheet
Registered number: 16314801

| 2026
--- | ---
|  | £
Current assets |  | 154,676
Creditors: Amounts Falling Due Within One Year |  | (44,723 )
NET CURRENT ASSETS |  | 109,953
TOTAL ASSETS LESS CURRENT LIABILITIES |  | 109,953
NET ASSETS |  | 109,953
CAPITAL AND RESERVES |  | 109,953

## Notes

1. General Information
Dynamic Pharma Consulting Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 16314801 . The registered office is 35 Church Street, Thriplow, Royston, SG8 7RE.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1
1
For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

Dr René Van Der Merwe Director
04/06/2026